JP2021527718A5 - - Google Patents

Info

Publication number
JP2021527718A5
JP2021527718A5 JP2021520455A JP2021520455A JP2021527718A5 JP 2021527718 A5 JP2021527718 A5 JP 2021527718A5 JP 2021520455 A JP2021520455 A JP 2021520455A JP 2021520455 A JP2021520455 A JP 2021520455A JP 2021527718 A5 JP2021527718 A5 JP 2021527718A5
Authority
JP
Japan
Prior art keywords
lactobacillus plantarum
nutritional supplement
pharmaceutical composition
probiotic strain
composition according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2021520455A
Other languages
English (en)
Japanese (ja)
Other versions
JP2021527718A (ja
JP7476183B2 (ja
Filing date
Publication date
Priority claimed from PCT/EP2018/066154 external-priority patent/WO2019242839A1/en
Application filed filed Critical
Publication of JP2021527718A publication Critical patent/JP2021527718A/ja
Publication of JP2021527718A5 publication Critical patent/JP2021527718A5/ja
Application granted granted Critical
Publication of JP7476183B2 publication Critical patent/JP7476183B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2021520455A 2018-06-18 2019-06-13 ラクトバチルス・プランタルムの組成物およびその使用 Active JP7476183B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
PCT/EP2018/066154 WO2019242839A1 (en) 2018-06-18 2018-06-18 Lactobacillus plantarum compositions and uses thereof
EPPCT/EP2018/066154 2018-06-18
PCT/EP2019/065590 WO2019243169A1 (en) 2018-06-18 2019-06-13 Lactobacillus plantarum compositions and uses thereof

Publications (3)

Publication Number Publication Date
JP2021527718A JP2021527718A (ja) 2021-10-14
JP2021527718A5 true JP2021527718A5 (enExample) 2022-05-17
JP7476183B2 JP7476183B2 (ja) 2024-04-30

Family

ID=62842054

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021520455A Active JP7476183B2 (ja) 2018-06-18 2019-06-13 ラクトバチルス・プランタルムの組成物およびその使用

Country Status (12)

Country Link
US (1) US12558385B2 (enExample)
EP (1) EP3806876B1 (enExample)
JP (1) JP7476183B2 (enExample)
KR (1) KR102770563B1 (enExample)
CN (1) CN112638393B (enExample)
AU (1) AU2018428571B2 (enExample)
BR (1) BR112020026076A2 (enExample)
CA (1) CA3102445A1 (enExample)
ES (1) ES2966935T3 (enExample)
MX (1) MX2020013860A (enExample)
PL (1) PL3806876T3 (enExample)
WO (2) WO2019242839A1 (enExample)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102770563B1 (ko) 2018-06-18 2025-02-21 프로비 에이비 락토바실러스 플란타룸 조성물 및 이의 용도
GB201908154D0 (en) * 2019-06-07 2019-07-24 Probi Ab Lactobacillus compositions and uses thereof

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1429802B1 (en) 2001-09-28 2012-11-07 TNTGamble, Inc. Delivery system for biological component
US20070098784A1 (en) 2001-09-28 2007-05-03 Nutraceutix, Inc. Delivery system for biological component
SE527555C2 (sv) * 2003-04-04 2006-04-11 Probi Ab Anti-inflammatorisk komposition innehållande tannasproducerande Lactobacillusstammar
WO2007040446A1 (en) * 2005-10-06 2007-04-12 Probi Ab Use of lactobacillus for treatment of autoimmune diseases
CN101325960B (zh) * 2005-10-06 2012-05-30 普罗比公司 乳酸杆菌用于治疗自身免疫性疾病的用途
SE532899C2 (sv) * 2007-06-08 2010-05-04 Probi Ab Förfarande genom fermentering med Lactobacillus plantarum för tillhandahållande av en insulinsvarsreducerande produkt och dess användning farmaceutiskt eller i livsmedel
SE533778C2 (sv) 2009-05-14 2011-01-11 Probi Ab Probiotisk fruktdryck
JP6103675B2 (ja) 2013-04-03 2017-03-29 プロビ アーベ 骨粗鬆症の治療または予防に使用するプロバイオティクス菌株
MA40071A (fr) 2014-07-01 2016-01-07 Probi Usa Inc Comprimés probiotiques bi-couche à double libération
CN108778300A (zh) 2015-10-07 2018-11-09 拜福丹公司 益生菌制剂
GB201600975D0 (en) * 2016-01-19 2016-03-02 Probi Ab Novel strain of probiotic bacteria and compositions and uses thereof
GB201708932D0 (en) 2017-06-05 2017-07-19 Probi Ab Microbial compositions
KR102770563B1 (ko) 2018-06-18 2025-02-21 프로비 에이비 락토바실러스 플란타룸 조성물 및 이의 용도

Similar Documents

Publication Publication Date Title
US10501530B2 (en) Probiotics, secretory IgA and inflammation
JP7523493B2 (ja) 情動的反応を制御するため、並びに潜在的な気分変調の治療及び予防のための、ビフィドバクテリウム・ロンガムを用いる、方法及び組成物
JP6444358B2 (ja) ペディオコッカスを含有する医薬組成物および消化器症候群の症状を低減する方法
JP2022180539A (ja) 精神疾患を予防及び／又は治療するためのラクトバチルス・プランタルム（Ｌａｃｔｏｂａｃｉｌｌｕｓ ｐｌａｎｔａｒｕｍ）を含む組成物
Rad et al. Might patients with immune-related diseases benefit from probiotics?
EP2308498A1 (en) Administration of Bifidobacterium breve during infancy to prevent inflammation later in life
JP6484561B2 (ja) Ｌａｃｔｏｂａｃｉｌｌｕｓｆｅｒｍｅｎｔｕｍ（ラクトバチルス・ファーメンタム）ｍｅ−３を用いる治療方法
JP7366540B2 (ja) メタボリックシンドローム治療用栄養補助食品および食品組成物
CN107405354A (zh) 治疗急性呼吸道感染的组合物和方法
AU2019359794B2 (en) Human dietary supplement and method for treating digestive system and immune-related disorders
JP7700109B2 (ja) 胃腸の健康組成物
JP2021527718A5 (enExample)
JP6050341B2 (ja) 改善された食品組成物
CN107980002A (zh) 使用长双岐杆菌优化母乳喂养的方法和组合物
JP2009057346A (ja) 免疫バランス調節用組成物
WO2023078603A1 (en) Oxytocin-mimetic compositions and uses thereof
Vijayaram et al. Probiotics: A multifaceted approach to health promotion-from disease prevention to food enrichment and delivery systems
US20250352589A1 (en) Oxytocin-mimetic compositions and uses thereof
CN116138457A (zh) 一种具有缓解抑郁样症状作用的复合营养组合物
US11020440B2 (en) Probiotic for the treatment of psoriasis
WO2026072929A1 (en) Compositions for treating gastrointestinal side effects of weight loss and diabetes medications
Kroeker et al. Treatment of Ulcerative Colitis
KOTWAL PROBIOTICS AND INFECTIOUS AGENTS BHARAT MENGI1, SK KOTWAL1 AND MANINDER SINGH1
Valmar AnMar Pharma
Calafiore et al. Gastroenterology and Hepatology Research